Skip to main content
Equibles
CRVS logo

CRVS · Corvus Pharmaceuticals, Inc. · Share Buybacks

Track CRVS — free

Use CRVS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CRVS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.52 -0.02 (-0.19%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$886.63M
Shares
84.12M
Volume · Oct 28 910.14K Avg daily vol (3M) 996.23K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2024-08-06 $200,000,000 $200,000,000 as of 2026-06-30 —
Key facts CIK 1626971 CUSIP 221015100 13F (30d) 21 filings 21 filers Visit website Investor relations